The phacoemulsification devices market is forecast to grow by USD 622.54 million between 2023 and 2028, driven by a CAGR of 5.36%, as healthcare systems worldwide ramp up efforts to tackle the increasing prevalence of cataracts. Technological innovations, rising global awareness, and expanding access to surgical procedures in emerging markets are accelerating adoption—especially in high-income nations such as the U.S., Canada, France, and Germany.
For more details about the industry, get the PDF sample report for free
Increasing Prevalence of Cataracts
Globally, four out of ten people are expected to develop cataracts during their lifetime. This condition is a leading cause of vision loss, and the number of cataract surgeries is projected to grow from over 20 million in 2017 to more than 35 million by 2025. According to the National Institutes of Health (NIH), over half of Americans aged 80 and above are affected by cataracts or have undergone cataract surgery.
Technological Advancements in Surgical Tools
Modern phacoemulsification systems use ultrasonic vibrations to emulsify and remove clouded lenses through minimally invasive procedures. These systems are equipped with specialized components such as phaco handpieces, tips, foot pedals, capsular tension rings, and more. Companies like Medical Technical Products have introduced devices such as F-Sonic phaco tip sets that enhance hold and efficiency during surgery.
Global Awareness and Accessibility Programs
Phacoemulsification is increasingly the preferred method for cataract treatment in both developed and developing countries. Programs such as Novartis’ Phaco Development Program in Asia are working to train ophthalmologists and hospitals to increase public access. These initiatives are transforming healthcare delivery by bridging gaps in surgical availability and capability across underserved regions.
The elderly population often suffers from both cataracts and glaucoma, leading to a trend in combined surgeries using phacoemulsification devices. These dual procedures not only reduce intraocular pressure (IOP) but also minimize the risks and costs of separate interventions. Ultrasonic surgical technologies facilitate safer and more efficient outcomes, which are essential in age-related ophthalmic care.
Cataract surgeries are increasingly performed in ophthalmologic clinics on an outpatient basis. Clinics benefit from a large customer base, enhanced by affordable treatment plans and aggressive promotional strategies. The rising number of specialized clinics focused solely on cataract surgeries is transforming the end-user landscape and driving market penetration.
One of the major hurdles for market adoption remains the cost of phacoemulsification systems. Advanced surgical tools offer better precision, smaller incisions, and improved recovery but are often out of budget for many hospitals and clinics, especially in developing countries. The capital-intensive nature of these devices is a barrier to widespread use, impacting purchasing decisions among healthcare providers with limited resources.
The market is segmented into the following categories.
Product Outlook
Phacoemulsification Consumables
Phacoemulsification Systems
End-user Outlook
Hospitals
Clinics
Research Institutes
Geography Outlook
North America: U.S., Canada
Europe: U.K., Germany, France
Asia: China, India
Rest of the World: Australia, Argentina, Brazil
The consumables segment—comprising handpieces, tips, foot pedals, and phaco packs—was valued at USD 988.24 million in 2018 and is projected to maintain strong momentum. These items are offered in single-use and reusable formats. Leading manufacturers such as Johnson & Johnson and Medical Technical Products are investing in product refinement to improve surgical precision and patient outcomes.
Hospitals dominate as the primary end-users, particularly those specializing in ophthalmic care. Strategic partnerships with device manufacturers enable hospitals to procure equipment at discounted rates, a critical factor in driving adoption. In developed regions, increased disposable income and heightened public awareness are further bolstering hospital-based surgeries.
Clinics are gaining ground due to the surge in outpatient cataract procedures. Their success is tied to the growth of independent ophthalmic centers, cost-effective service offerings, and flexibility in treatment schedules, making them an accessible choice for many patients.
Countries: United States, Canada
North America is expected to contribute 40% of the global market growth. The region benefits from increased public healthcare spending, with U.S. per capita healthcare expenditure reaching USD 12,914 in 2021, according to The World Bank. Additional factors include robust healthcare infrastructure, favorable reimbursement policies, and the strong presence of global device manufacturers.
Countries: United Kingdom, Germany, France
Europe shows continued adoption, particularly driven by technological adoption and aging populations. Government and private initiatives in the U.K., Germany, and France support a well-regulated environment for phaco surgeries.
Countries: China, India
Growth in Asia is catalyzed by increased cataract awareness, training programs, and regional investments in public eye care. Initiatives like Novartis’ training programs in Asia are boosting capacity for cataract procedures across major hospitals.
Countries: Australia, Argentina, Brazil
These regions are showing moderate growth, supported by emerging healthcare systems, increasing access to vision care, and global partnership programs enhancing device availability and training.
Get more details by ordering the complete report
The Phacoemulsification Devices Market is experiencing significant growth, driven by the increasing prevalence of cataract diseases and the rising demand for effective blindness treatment. Cataract surgery remains one of the most common procedures in ophthalmology, with phacoemulsification systems playing a pivotal role in the lens fragmentation process. The adoption of advanced phaco technology has enhanced the effectiveness and safety of cataract removal, using ultrasonic handpieces and phaco handpieces to break down the cloudy eye lens. Moreover, phaco consumables, including phaco tips, phaco packs, and capsular tension rings, are essential components, helping achieve optimal surgical outcomes. The market is also supported by increased hospital equipment and clinic tools, as well as specialized ophthalmology devices designed for eye health and vision care.
Several global companies are actively expanding their footprint through strategic partnerships, product launches, and acquisitions:
These companies are categorized based on their strategic approach—ranging from pure-play to diversified players—and evaluated by their market performance as dominant, leading, strong, tentative, or weak.
Research in the Phacoemulsification Devices Market highlights continued innovation in ophthalmic surgery, with lens aspiration, phaco tip sets, and foot pedals improving the precision of cataract extraction procedures. The market also shows a shift toward the use of both disposable consumables and reusable consumables, enabling cost-effective solutions for eye treatment. With advancements in surgical tools and ophthalmic surgery techniques, surgical innovation continues to enhance patient outcomes. The growing demand for ophthalmology care is also being driven by increased healthcare infrastructure and a focus on blindness prevention and vision impairment management. Research institutes are continually exploring new ways to improve eye diseases management, ensuring the availability of the latest medical devices to treat lens clouding and other age-related vision issues.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
